4 Cos. Join Busy IPO Pipeline With Launches Totaling $598M
Three venture-backed biotechnology firms on Monday set price ranges for initial public offerings estimated to raise $300 million combined and a Chinese software developer is eyeing a $298 million IPO, adding...To view the full article, register now.
Already a subscriber? Click here to view full article